71 related articles for article (PubMed ID: 2872863)
1. Antagonism of bencianol (ZY 15051) and idazoxan (RX 781094) to norepinephrine in feline pial arteries in situ.
Wahl M; Schilling L
Arch Int Pharmacodyn Ther; 1986 Apr; 280(2):205-15. PubMed ID: 2872863
[TBL] [Abstract][Full Text] [Related]
2. Selectivity and potency of 2-alkyl analogues of the alpha 2-adrenoceptor antagonist idazoxan (RX 781094) in peripheral systems.
Doxey JC; Roach AG; Strachan DA; Virdee NK
Br J Pharmacol; 1984 Nov; 83(3):713-22. PubMed ID: 6150740
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of smooth muscle alpha adrenoceptors in rat tail artery in vitro.
Medgett IC; Langer SZ
J Pharmacol Exp Ther; 1984 Jun; 229(3):823-30. PubMed ID: 6144792
[TBL] [Abstract][Full Text] [Related]
4. Smooth muscle alpha-2 adrenoceptors mediate vasoconstrictor responses to exogenous norepinephrine and to sympathetic stimulation to a greater extent in spontaneously hypertensive than in Wistar Kyoto rat tail arteries.
Medgett IC; Hicks PE; Langer SZ
J Pharmacol Exp Ther; 1984 Oct; 231(1):159-65. PubMed ID: 6149302
[TBL] [Abstract][Full Text] [Related]
5. Differential blocking actions of idazoxan against the inhibitory effects of 6-fluoronoradrenaline and clonidine in the rat vas deferens.
Hicks PE; Langer SZ; Macrae AD
Br J Pharmacol; 1985 Sep; 86(1):141-50. PubMed ID: 2864967
[TBL] [Abstract][Full Text] [Related]
6. Alpha-blocking properties of idazoxan (170150 or RX 781094) and its stereoisomers: applications to bronchomotricity.
Floch A; Advenier C
J Pharmacol; 1985; 16(3):291-7. PubMed ID: 2866275
[TBL] [Abstract][Full Text] [Related]
7. Increased pressor responsiveness of femoral arteries to exogenous norepinephrine in renal hypertensive dogs mediated through alpha 2 adrenoceptors.
Xu B; Chen RX; Chen DG
Zhongguo Yao Li Xue Bao; 1993 May; 14(3):229-31. PubMed ID: 7901962
[TBL] [Abstract][Full Text] [Related]
8. The alpha adrenoceptor antagonist properties of idazoxan in normal subjects.
Elliott HL; Jones CR; Vincent J; Lawrie CB; Reid JL
Clin Pharmacol Ther; 1984 Aug; 36(2):190-6. PubMed ID: 6146423
[TBL] [Abstract][Full Text] [Related]
9. Idazoxan effects upon contractile activity in the rat aorta are related to alpha adrenoceptors and L-type channels.
Serban DN; Serban IL; Nechifor M
Fundam Clin Pharmacol; 2004 Dec; 18(6):635-41. PubMed ID: 15548234
[TBL] [Abstract][Full Text] [Related]
10. Responses to norepinephrine resistant to inhibition by alpha and beta adrenoceptor antagonists.
Bond RA; Charlton KG; Clarke DE
J Pharmacol Exp Ther; 1986 Feb; 236(2):408-15. PubMed ID: 2868118
[TBL] [Abstract][Full Text] [Related]
11. Postsynaptic alpha 2-adrenergic receptor-mediated vasoconstriction in SHR tail arteries in vitro.
Hicks PE; Medgett IC; Langer SZ
Hypertension; 1984; 6(2 Pt 2):I12-8. PubMed ID: 6144633
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of xylazine hydrochloride as the sole immobilizing agent in moose and caribou--and its subsequent reversal with idazoxan.
Doherty TJ; Tweedie DP
J Wildl Dis; 1989 Jan; 25(1):95-8. PubMed ID: 2563404
[TBL] [Abstract][Full Text] [Related]
13. Peripheral pre and postjunctional alpha 2-adrenoceptors in man: studies with RX781094, a selective alpha 2 antagonist.
Elliott HL; Jones CR; Reid JL
J Hypertens Suppl; 1983 Dec; 1(2):109-11. PubMed ID: 6152738
[TBL] [Abstract][Full Text] [Related]
14. Prolactin-lowering ability of (+/-)-idazoxan may be linked to a central noradrenergic-serotonergic interplay.
Preziosi P; Martire M; Navarra P; Pistritto G; Vacca M
J Pharmacol Exp Ther; 1989 Apr; 249(1):256-63. PubMed ID: 2565391
[TBL] [Abstract][Full Text] [Related]
15. A study of the selectivity and potency of rauwolscine, RX 781094 and RS 21361 as antagonists of alpha-1 and alpha-2 adrenoceptors.
Timmermans PB; Qian JQ; Ruffolo RR; van Zwieten PA
J Pharmacol Exp Ther; 1984 Mar; 228(3):739-48. PubMed ID: 6142941
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the presence of postjunctional alpha-2 adrenoceptors in the rat anococcygeus muscle.
Ramagopal MV; Leighton HJ
J Pharmacol Exp Ther; 1989 Aug; 250(2):492-9. PubMed ID: 2547934
[TBL] [Abstract][Full Text] [Related]
17. Human vascular smooth muscle responses mediated by alpha 2 mechanisms in vivo and in vitro.
Thom S; Calvete J; Hayes R; Martin G; Sever P
Clin Sci (Lond); 1985; 68 Suppl 10():147s-150s. PubMed ID: 2857611
[TBL] [Abstract][Full Text] [Related]
18. [Action of idazoxan on tachycardia following electric stimulation of the thoracic sympathetic chain in the rat].
Dabiré H; Fournier B; Schmitt H
C R Seances Soc Biol Fil; 1986; 180(2):170-3. PubMed ID: 2877721
[TBL] [Abstract][Full Text] [Related]
19. GYKI-12 743, a novel antihypertensive compound with special alpha-adrenergic blocking profile.
Jaszlits L; Rabloczky G; Csókás G; Bódi I; Kürthy M; Horváth E; Kovács A; Jednákovits A; Arányi P; Mátyus P
Acta Physiol Hung; 1990; 75 Suppl():155-6. PubMed ID: 1973559
[No Abstract] [Full Text] [Related]
20. Failure of selective antagonists (CH-38083 and idazoxan) to distinguish between prejunctional and postjunctional alpha 2-adrenoreceptors.
Lonart G; Harsing LG; Folly G; Vizi ES
J Auton Pharmacol; 1989 Apr; 9(2):149-58. PubMed ID: 2565902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
